Shandong Weigao Orthopaedic Device Co., Ltd (SHA:688161)
China flag China · Delayed Price · Currency is CNY
27.63
-0.63 (-2.23%)
At close: May 14, 2026

SHA:688161 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,5271,5211,4511,2822,0572,152
Other Revenue
1.921.922.211.330.931.58
1,5291,5231,4531,2842,0582,154
Revenue Growth (YoY)
9.60%4.82%13.18%-37.63%-4.44%18.08%
Cost of Revenue
578.7566.99537.6460.3489.5409.09
Gross Profit
950.24955.8915.12823.241,5681,744
Selling, General & Admin
551.75547.75573.21621.81786.46827.36
Research & Development
108.73112.3119.9130.2117.66121.23
Other Operating Expenses
13.3514.5813.7314.2128.8931.26
Operating Expenses
686.02682.26698.56760.93948.03983.99
Operating Income
264.22273.54216.5662.31620.45760.46
Interest Expense
-1.07-0.98-1.04-0.95-0.61-0.61
Interest & Investment Income
40.846.1644.856.1164.5742.93
Currency Exchange Gain (Loss)
-4.47-4.47-1-1.242.18-0.51
Other Non Operating Income (Expenses)
-0.850.11-1.1810.586.02-6.28
EBT Excluding Unusual Items
298.64314.37258.14126.82692.6795.99
Impairment of Goodwill
-0.11-0.11-0.24-0.17--
Gain (Loss) on Sale of Investments
0.761.250.320.13--
Gain (Loss) on Sale of Assets
0.070.056.35-0.020.23-0.11
Asset Writedown
0.06-----
Other Unusual Items
8.518.516.364.8613.3814.05
Pretax Income
307.91324.07270.94131.62706.21809.93
Income Tax Expense
43.3450.2642.6618.53105.85118.59
Earnings From Continuing Operations
264.57273.8228.29113.09600.36691.33
Minority Interest in Earnings
-3.49-5.16-4.53-0.780.35-1.01
Net Income
261.08268.64223.75112.32600.7690.32
Net Income to Common
261.08268.64223.75112.32600.7690.32
Net Income Growth
8.50%20.06%99.22%-81.30%-12.98%23.62%
Shares Outstanding (Basic)
396395400401400379
Shares Outstanding (Diluted)
402401400401400379
Shares Change (YoY)
-0.07%0.35%-0.39%0.16%5.58%5.96%
EPS (Basic)
0.660.680.560.281.501.82
EPS (Diluted)
0.650.670.560.281.501.82
EPS Growth
8.58%19.64%100.00%-81.33%-17.58%16.67%
Free Cash Flow
366.09388.33249.8576.46392.8675.84
Free Cash Flow Per Share
0.910.970.630.190.981.78
Dividend Per Share
0.3400.3400.2900.1200.4100.520
Dividend Growth
17.24%17.24%140.70%-70.62%-21.15%-
Gross Margin
62.15%62.77%62.99%64.14%76.22%81.00%
Operating Margin
17.28%17.96%14.91%4.86%30.15%35.31%
Profit Margin
17.08%17.64%15.40%8.75%29.19%32.05%
Free Cash Flow Margin
23.94%25.50%17.20%5.96%19.09%31.38%
EBITDA
312.38324.13276.88120.22677.35811.94
EBITDA Margin
20.43%21.29%19.06%9.37%32.91%37.70%
D&A For EBITDA
48.1650.5960.3357.9156.9151.48
EBIT
264.22273.54216.5662.31620.45760.46
EBIT Margin
17.28%17.96%14.91%4.86%30.15%35.31%
Effective Tax Rate
14.08%15.51%15.74%14.08%14.99%14.64%
Revenue as Reported
1,5291,5231,453-2,0582,154
Source: S&P Global Market Intelligence. Standard template. Financial Sources.